These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24683542)

  • 41. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
    Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
    Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer.
    Shi H; Zhou S; Liu J; Zhu J; Xue J; Gu L; Chen Y
    Pathol Res Pract; 2016 May; 212(5):444-9. PubMed ID: 26944831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiRNA-34a overexpression inhibits multiple myeloma cancer stem cell growth in mice by suppressing TGIF2.
    Wu S; He X; Li M; Shi F; Wu D; Pan M; Guo M; Zhang R; Luo S; Gu N; Dou J
    Am J Transl Res; 2016; 8(12):5433-5443. PubMed ID: 28078014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
    Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG
    BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
    Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
    Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
    Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
    Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of MDM4 Gene Regulation by miR-34a on LOVO Cell Proliferation.
    Li S; Pei Y; Zhang W; Sun L; Jiang M; Shang G; Niu S; Ma Z
    Ann Clin Lab Sci; 2020 May; 50(3):342-347. PubMed ID: 32581023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis.
    Hui C; Yujie F; Lijia Y; Long Y; Hongxia X; Yong Z; Jundong Z; Qianyong Z; Mantian M
    Breast Cancer Res; 2012 May; 14(3):R80. PubMed ID: 22616882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
    Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
    Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation.
    Xu S; Liu Y; Tai HC; Zhu J; Ding H; Lee RJ
    Int J Pharm; 2011 Feb; 404(1-2):205-10. PubMed ID: 21056642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic regulation of miR-34a expression in alcoholic liver injury.
    Meng F; Glaser SS; Francis H; Yang F; Han Y; Stokes A; Staloch D; McCarra J; Liu J; Venter J; Zhao H; Liu X; Francis T; Swendsen S; Liu CG; Tsukamoto H; Alpini G
    Am J Pathol; 2012 Sep; 181(3):804-17. PubMed ID: 22841474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
    Yan X; Tang B; Chen B; Shan Y; Yang H;
    Elife; 2019 Mar; 8():. PubMed ID: 30860027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells.
    Chen L; Holmstrøm K; Qiu W; Ditzel N; Shi K; Hokland L; Kassem M
    Stem Cells; 2014 Apr; 32(4):902-12. PubMed ID: 24307639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.
    Khajavinia A; Varshosaz J; Dehkordi AJ
    Nanotechnology; 2012 Oct; 23(40):405101. PubMed ID: 22983592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2.
    Su G; Sun G; Liu H; Shu L; Liang Z
    Heart Vessels; 2018 Oct; 33(10):1185-1194. PubMed ID: 29704100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
    Liu X; Liu X; Wu Y; Fang Z; Wu Q; Wu C; Hao Y; Yang X; Zhao J; Li J; Wang Q; Yang Z; Xu J; Hu X; Tan M; Li L
    Cell Physiol Biochem; 2018; 48(1):87-98. PubMed ID: 30001529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-34a expands myeloid-derived suppressor cells via apoptosis inhibition.
    Huang A; Zhang H; Chen S; Xia F; Yang Y; Dong F; Sun D; Xiong S; Zhang J
    Exp Cell Res; 2014 Aug; 326(2):259-66. PubMed ID: 24780820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and validation of microRNAs that synergize with miR-34a - a basis for combinatorial microRNA therapeutics.
    Orellana EA; Li C; Lisevick A; Kasinski AL
    Cell Cycle; 2019 Aug; 18(15):1798-1811. PubMed ID: 31258013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.